IV Therapy: Life-Saving Medicines Used in Everyday Hospital Care
IV therapy offers healthcare professionals a reliable and effective way to administer infusion solutions and medicines intravenously. It is commonly used in hospitals and ambulatory environments because it is easy to dose and can act quickly. IV therapy can be administered by a pump on dosage control, by gravity drip or by bolus injection. We work together with healthcare professionals to fully understand how we can improve our products in order to make their daily work easier. One such example is injectable drugs available as prediluted ready-to-administer dosage form in infusion bags or bottles, pre-filled syringes or custom implementation for individual dosing. Ready-to-administer products eliminate preparation steps of the IV drugs and enable healthcare professionals to react quickly and safely, especially during emergency situations.
Fresenius Kabi is one of the leading providers of high-quality products for IV therapy worldwide with decades of experience. Our IV therapy products fall into two main groups: IV drugs and fluids. Both are essential components of modern healthcare and support medical professionals every day in caring for critically ill patients.
IV fluids for almost every situation in hospital life
It’s often the most familiar things that get the least attention – but not at Fresenius Kabi. We give our IV fluids the consideration they deserve because we recognize how essential they are to daily life in healthcare.
In emergencies, patients may be in a life-threatening situation, suffering from blood loss or dehydration. With the help of our IV fluids, healthcare professionals can restore this fluid loss. Depending on what is needed, they can use our electrolyte solutions and colloids, which we offer in a vast variety of sizes and different containers. They are reliable, easy to use, and quick to deliver.
~1.4 billion units of IV fluids sold annually
>160 IV drugs in portfolio
With a portfolio of more than 160 IV drugs, Fresenius Kabi provides comprehensive products for a wide range of medical conditions and are amongst the largest hospital supplier of IV generic drugs in many of the countries we operate in. We are dedicated to improving patient care by delivering reliable, high-quality medicines.
At Fresenius Kabi, we understand the importance of comprehensive healthcare solutions. Beyond our diverse range of IV drugs and fluids, we are also one of the largest manufacturers of IV bags in the world, which feature a unique port design to ensure safety and convenience. We aim to provide a comprehensive range of system critical IV therapies, maintaining the highest standards of quality and safety to support daily work in hospitals.
Whether in production, research, or clinical application, safety always comes first. To ensure this, we have installed a special safety concept. The goal of all measures is always to ensure that our products are safe – both for the patient and for the person administering them. For example, we employ a user-friendly color safety concept for all of our packaging. This color system is complying with national and international standards. We also offer needle-free connectors to help reduce the risk of accidental needle punctures (and consequent infections) for healthcare professionals. We also developed OncoShield to offer maximum safety for people working with cytotoxic drugs. OncoShield vial sleeves are protected against breakage from impact during transport and for use in pharmacy settings.
Outstanding quality defines all facets of our work, and our Research & Development Team is constantly scrutinizing our own processes in order to optimize wherever possible. And for us, innovation goes far beyond launching new generic products on the market on a continuous basis. We modify existing products and adapt them for faster and more efficient use based on the evolving needs of healthcare professionals. At the end of the day, this saves valuable time, which healthcare professionals can then use for the care of their patients.
